These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 9467564

  • 21. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
    Gill MS, Toogood AA, Jones J, Clayton PE, Shalet SM.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
    [Abstract] [Full Text] [Related]

  • 22. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [Abstract] [Full Text] [Related]

  • 23. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [Abstract] [Full Text] [Related]

  • 24. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
    Popovic V, Mattsson AF, Gaillard RC, Wilton P, Koltowska-Häggström M, Ranke MB.
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
    [Abstract] [Full Text] [Related]

  • 25. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction.
    Reeves I, Abribat T, Laramee P, Jasmin G, Brazeau P.
    Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745
    [Abstract] [Full Text] [Related]

  • 26. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C, Woods KA, Miraki-Moud F, Hindmarsh PC, Clark AJ, Hansson Y, Johnston A, Baxter RC, Savage MO.
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [Abstract] [Full Text] [Related]

  • 27. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 28. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.
    Kawachi S, Takeda N, Sasaki A, Kokubo Y, Takami K, Sarui H, Hayashi M, Yamakita N, Yasuda K.
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):617-21. PubMed ID: 15625284
    [Abstract] [Full Text] [Related]

  • 29. A low starting dose of genotropin in growth hormone-deficient adults.
    Janssen YJ, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):129-35. PubMed ID: 8989246
    [Abstract] [Full Text] [Related]

  • 30. Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study.
    Argüelles B, Barrios V, Pozo J, Muñoz MT, Argente J.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4087-92. PubMed ID: 11095437
    [Abstract] [Full Text] [Related]

  • 31. Urinary growth hormone (GH), insulin-like growth factor I (IGF-I), and IGF-binding protein-3 measurements in the diagnosis of adult GH deficiency.
    Gill MS, Toogood AA, O'Neill PA, Thorner MO, Shalet SM, Clayton PE.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2562-5. PubMed ID: 9661643
    [Abstract] [Full Text] [Related]

  • 32. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [Abstract] [Full Text] [Related]

  • 33. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 34. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.
    Colao A, Spiezia S, Di Somma C, Pivonello R, Marzullo P, Rota F, Musella T, Auriemma RS, De Martino MC, Lombardi G.
    J Endocrinol Invest; 2005 May; 28(5):440-8. PubMed ID: 16075928
    [Abstract] [Full Text] [Related]

  • 35. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A, Brismar K, Degerblad M, Thorén M, Hall K.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D, Tacchino RM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [Abstract] [Full Text] [Related]

  • 38. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
    Papastathi C, Mavrommatis A, Mentzelopoulos S, Konstandelou E, Alevizaki M, Zakynthinos S.
    Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
    [Abstract] [Full Text] [Related]

  • 39. Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters.
    Hindmarsh PC, Fall CH, Pringle PJ, Osmond C, Brook CG.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2172-6. PubMed ID: 9215290
    [Abstract] [Full Text] [Related]

  • 40. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C, Duron F, Binoux M.
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.